HALEON US HOLDINGS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HALEON US HOLDINGS, and when can generic versions of HALEON US HOLDINGS drugs launch?
HALEON US HOLDINGS has thirty-one approved drugs.
There are ten US patents protecting HALEON US HOLDINGS drugs.
There are two hundred and three patent family members on HALEON US HOLDINGS drugs in thirty-two countries and sixteen supplementary protection certificates in eight countries.
Summary for HALEON US HOLDINGS
| International Patents: | 203 |
| US Patents: | 10 |
| Tradenames: | 28 |
| Ingredients: | 18 |
| NDAs: | 31 |
Drugs and US Patents for HALEON US HOLDINGS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | PEDIATRIC ADVIL | ibuprofen | SUSPENSION/DROPS;ORAL | 020812-001 | Jan 30, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Haleon Us Holdings | NICORETTE (MINT) | nicotine polacrilex | GUM, CHEWING;BUCCAL | 018612-003 | Dec 23, 1998 | OTC | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Haleon Us Holdings | ADVIL PM | diphenhydramine hydrochloride; ibuprofen | CAPSULE;ORAL | 021393-001 | Dec 21, 2005 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Haleon Us Holdings | NICORETTE | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 021330-001 | Oct 31, 2002 | OTC | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Haleon Us Holdings | NICORETTE | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 022360-001 | May 18, 2009 | OTC | Yes | No | 8,940,772 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Haleon Us Holdings | TAVIST-1 | clemastine fumarate | TABLET;ORAL | 020925-001 | Aug 21, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Haleon Us Holdings | FLONASE SENSIMIST ALLERGY RELIEF | fluticasone furoate | SPRAY, METERED;NASAL | 022051-002 | Aug 2, 2016 | OTC | Yes | Yes | 9,320,862 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HALEON US HOLDINGS
Paragraph IV (Patent) Challenges for HALEON US HOLDINGS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 200 mg/38 mg | ➤ Subscribe | 2016-02-16 |
| ➤ Subscribe | Gum | 2 mg | ➤ Subscribe | 2013-01-22 |
| ➤ Subscribe | Capsules | 200 mg/30 mg | ➤ Subscribe | 2004-12-27 |
| ➤ Subscribe | Capsules | 60 mg | ➤ Subscribe | 2010-09-08 |
| ➤ Subscribe | Gum | 4 mg | ➤ Subscribe | 2013-01-22 |
International Patents for HALEON US HOLDINGS Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2004012799 | ⤷ Sign Up |
| Germany | 60328883 | ⤷ Sign Up |
| Japan | 2008501692 | ⤷ Sign Up |
| Austria | E534589 | ⤷ Sign Up |
| Mexico | 2007012511 | ⤷ Sign Up |
| South Africa | 200408031 | ⤷ Sign Up |
| Israel | 288989 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for HALEON US HOLDINGS Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1519731 | 132013902182575 | Italy | ⤷ Sign Up | PRODUCT NAME: AZELASTINA CLORIDRATO/FLUTICASONE PROPIONATO(DYMISTA); AUTHORISATION NUMBER(S) AND DATE(S): 2011/07125-REG, 20111024;041808015/M-027/M-039/M-041/M, 20130527 |
| 1305329 | SPC/GB08/026 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: FLUTICASONE FUROATE AND SOLVATES THEREOF; REGISTERED: UK EU/1/07/434/001 20080116; UK EU/1/07/434/002 20080116; UK EU/1/07/434/003 20080116 |
| 1781277 | PA2024501 | Lithuania | ⤷ Sign Up | PRODUCT NAME: IBUPROFENO IR PARACETAMOLIO DERINYS; REGISTRATION NO/DATE: LT/1/23/5212/001-002 20230726 |
| 0129748 | 98C0042 | Belgium | ⤷ Sign Up | PRODUCT NAME: ORLISTAT; REGISTRATION NO/DATE: EU/1/98/071/001 19980729 |
| 0428642 | 07C0081 | France | ⤷ Sign Up | PRODUCT NAME: DOCOSANOL; REGISTRATION NO/DATE IN FRANCE: NL 33457 DU 20070821; REGISTRATION NO/DATE AT EEC: 18517 DU 20031114 |
| 2506844 | 2018C/022 | Belgium | ⤷ Sign Up | PRODUCT NAME: EEN FARMACEUTISCH COMBINATIEPRODUCT DAT EEN FARMACEUTISCH AANVAARDBAAR ZOUT VAN UMECLIDINIUM (BV. UMECLIDINIUMBROMIDE), VILANTEROL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN (BV. VILANTEROLTRIFENATAAT) EN FLUTICASONEFUROAAT OMVAT; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117 |
| 2506844 | LUC00077 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: PRODUIT DE COMBINAISON PHARMACEUTIQUE COMPRENANT UN SEL PHARMACEUTIQUEMENT ACCEPTABLE D'UMECLIDINIUM (PAR EXEMPLE LE BROMURE D'UMECLIDINIUM), LE VILANTEROL OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE (PAR EXEMPLE LE TRIFENATATE DE VILANTEROL) ET LE FUROATE DE FLUTICASONE; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
